Suchergebnisse - "Liao, Ran"

PubPharm (5)

1

Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin : results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4)

enthalten in: The British journal of dermatology | 2022

von Bieber, T. | Reich, K. | Paul, C. | +13

2

Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation : an exploratory, randomised, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Ely, E. | Ramanan, A. | Kartman, C. | +25

CommentIn: Lancet Respir Med. 2022 Apr;10(4):314-315. - PMID 35123659

3

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Marconi, V. | Ramanan, A. | de Bono, S. | +105

CommentIn: Lancet Respir Med. 2021 Dec;9(12):1349-1351. - PMID 34480862

4

Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis : study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)

enthalten in: Trials | 2021

von Ramanan, A. | Guly, C. | Keller, S. | +4

5

Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis

enthalten in: RMD open | 2020

von Harigai, M. | Winthrop, K. | Takeuchi, T. | +9

1
[1]